GoodRx Holdings, Inc. / Fundamentals

    Income statement

    Net revenue
    €686.29M
    Cost of goods sold
    €60.33M
    Gross profit
    €625.96M
    SG&A expenses
    €394.15M
    R&D expenses
    €105.49M
    EBITDA
    €134.57M
    D&A
    €66.30M
    EBIT
    €76.94M
    Interest expenses
    €20.42M
    EBT
    €47.85M
    Tax expenses
    €8.52M
    Net income
    €46.44M

    Cash flow statement

    Net deferred tax
    -€550.84K
    Non-cash items
    €24.17M
    Changes in working capital
    €32.33M
    Operating cash flow
    €163.53M
    Capex
    €28.34M
    Other investing cash flow
    -€89.54M
    Net investing cash flow
    -€88.11M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €738.74K
    Debt repayment
    -€139.84M
    Other financing cash flow
    -€17.54M
    Net financing cash flow
    -€284.42M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€82.56M
    Cash at end of period
    €241.37M
    Free cash flow
    €191.88M

    Balance sheet

    Cash and cash equivalents
    €241.37M
    Cash and short-term investments
    €241.37M
    Total receivables
    €173.58M
    Inventory
    €0.00
    Other current assets
    €57.48M
    Total current assets
    €472.43M
    Property, plant & equipment
    €35.54M
    Goodwill
    €361.84M
    Intangible assets
    €174.91M
    Long-term investments
    €12.87M
    Other non-current assets
    €7.65M
    Total non-current assets
    €659.02M
    Total assets
    €1.13B
    Accounts payable
    €21.80M
    Short-term debt
    €8.43M
    Other current liabilities
    €76.88M
    Total current liabilities
    €112.32M
    Long-term debt
    €461.36M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €6.05M
    Total non-current liabilities
    €467.41M
    Total liabilities
    €579.73M
    Common stock
    €30.03K
    Retained earnings
    -€1.22B
    Other equity
    €0.00
    Total equity
    €551.72M
    Total liabilities and shareholders' equity
    €1.13B

    Company information

    Market capitalization
    €1.49B
    Employees
    738
    Enterprise Value
    €1.37B

    Company ratios

    Gross margin
    91.2% Much better than peer group: 58.0%
    EBITDA margin
    19.6% Much better than peer group: -1.2%
    EBIT margin
    11.2% Much better than peer group: -9.3%
    EBT margin
    7.0% Much better than peer group: -538.5%
    Net margin
    6.8% Better than peer group: -11.2%
    ROE
    8.4% Better than peer group: -1.1%
    ROA
    4.1% Better than peer group: -4.2%
    Asset turnover
    60.7% Much worse than peer group: 146.9%
    FCF margin
    19.7% Better than peer group: 2.2%
    FCF yield
    9.1%
    Efficiency ratio
    80.4%
    Net sales per employee
    €929.94K
    Net income per employee
    €62.93K

    Notifications